GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shortwave Life Sciences PLC (AQSE:PSY) » Definitions » Purchase Of Investment

Shortwave Life Sciences (AQSE:PSY) Purchase Of Investment : £ Mil (TTM As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Shortwave Life Sciences Purchase Of Investment?

Shortwave Life Sciences's purchase of investment for the six months ended in . 20 was £0.00 Mil. It means Shortwave Life Sciences spent £0.00 Mil on purchasing investments.

Compared with last quarter (£0.00 Mil in . 20 ), Shortwave Life Sciences spent the same money on purchasing investments in . 20 (£0.00 Mil).


Shortwave Life Sciences Purchase Of Investment Historical Data

The historical data trend for Shortwave Life Sciences's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shortwave Life Sciences Purchase Of Investment Chart

Shortwave Life Sciences Annual Data
Trend
Purchase Of Investment

Shortwave Life Sciences Semi-Annual Data
Purchase Of Investment

Shortwave Life Sciences Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.


Shortwave Life Sciences Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Shortwave Life Sciences's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Shortwave Life Sciences Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Shortwave Life Sciences PLC is a biopharmaceutical company focused in advancing pioneering therapies in mental health care, also it is involved in developing novel drug combinations and delivery methods to treat patients suffering from mental health disorders. It identifies, operates and creates value from early-stage, breakthrough initiatives, with an initial focus on eating disorders.

Shortwave Life Sciences Headlines